Filter
1228
Text search:
Vaccine
production
Featured
140
297
Language
Document type
496
291
181
92
74
46
15
15
6
4
4
2
1
1
Countries
95
36
35
34
32
27
26
25
24
23
20
18
17
16
16
15
14
13
13
12
11
11
11
10
10
10
9
9
9
8
8
8
7
7
7
7
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
451
129
65
56
53
21
6
Toolboxes
214
59
58
54
46
43
43
37
32
29
27
25
23
19
19
19
17
14
12
11
10
7
6
4
1
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
A call for national and regional containment, recovery and prevention
10 points from field experience
Ending Cholera. A global roadmap to 2030
recommended
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
DHS Comparative Reports No. 42
The purpose of this document is to inform the public about biological and chemical hazards and thereby prepare the population for an immediate response in the event of an incident until public health support is provided.
The agents reported here are: Anthrax, Botulism, Haemorrhagic Fever,
...
